mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |